China's first self-developed medical imaging device PET enters final clinical trial
By Pan Zhaoyi
["china"]
China’s first fully-digital PET (short for positron emission tomography) has entered the final phase of its clinical trials, a huge step for breaking up the foreign market monopoly in this field.
PETs have long been used for diagnosing cancer or other cardiovascular diseases, and have an advantage over other medical imaging methods such as CT scans, X-rays and magnetic resonance imaging (MRI).
These cutting-edge devices are able to spot cancer, dementia, Parkinson disease at a very early stage.
The equipment is undergoing clinical trials at the First Affiliated Hospital of Sun Yat-sen University and Sun Yat-sen University Cancer Center in Guangdong Province.
According to Xie Qingguo, leader of the project in China's Huazhong University of Science and Technology, the medical imaging technology developed by his team has been granted several patents, both domestically and abroad.
The breakthrough will help Chinese patients have more access to the advanced technology at a much lower cost.